Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation. Evogliptin tartrate is a potent, orally bioavailable and selective dipeptidyl peptidase-4 (DPP-4) inhibitor, with antidiabetic activity.
Molecular Weight:
551.51
CAS Number:
[1222102-51-3]
Formula:
C23H32F3N3O9
Target:
Autophagy|||Proteasome|||DPP-4
T11248
* VAT and and shipping costs not included. Errors and price changes excepted